Media-OutReach Newswire GangaGen Secures additional US$7.9 Million from CARB-X for Pre-clinical Development of Novel Klebicins Targeting Nosocomial Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae
Media-OutReach Newswire VinBrain and Global Fund continue joining forces to tackle Vietnam's tuberculosis challenge through AI in 2024